Syndromic epidermal differentiation disorders: a new classification toward pathogenesis-based therapy.

Area of Science:

• Genetics and Molecular Biology
• Dermatology
• Rare Diseases

Background:

• The 2010 ichthyosis classification has been updated with increased understanding of hereditary epidermal differentiation disorders (EDDs).
• A new classification based on gene and protein function focuses on shared disease pathogenesis mechanisms.
• EDDs are now categorized into syndromic (sEDD), nonsyndromic skin/appendage (nEDD), and palmoplantar (pEDD) types.

Purpose of the Study:

• To introduce a new classification system for EDDs based on gene and protein function.
• To highlight the potential for targeted therapies based on disease mechanisms.
• To discuss the clinical implications, particularly for rare syndromic EDDs.

Main Methods:

• Review and synthesis of current knowledge on EDDs.
• Development of a gene- and protein product function-based classification.
• Analysis of clinical features, extracutaneous manifestations, and therapeutic strategies for sEDDs.

Main Results:

• Syndromic EDDs (sEDDs) often present with extracutaneous features, including neurologic, ophthalmologic, and hair abnormalities.
• Common sEDDs include STS-sEDD and SPINK5-sEDD.
• Pathogenesis-based therapies, such as topical lovastatin-cholesterol and kallikrein inhibitors, show promise.
• Gene editing and cDNA introduction are potential future therapeutic avenues.

Conclusions:

• The new EDD classification facilitates a deeper understanding of disease mechanisms and therapeutic targets.
• Pathogenesis-based therapies offer new hope for managing rare sEDDs.
• Further research is needed to define the natural history and genotype-phenotype relationships of sEDDs.